Summary of US FDA GRAS Acceptance and Approval Status in the Third Quarter of 2024

S.N.

GRN No.

Substance

Notifier

1

1182

Hydroxytyrosol

Hangzhou Viablife Biotech Co, Ltd. (China)

2

1183

Rebaudioside M from a modified strain of Escherichia coli BL21(DE3)

Oobli, Inc. (U.S.)

3

1184

Rebaudioside M from a modified strain of Escherichia coli BL21(DE3)

Sichuan Ingia Biosynthetic Co., Ltd.（China）

4

1185

Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. FJRK-SCH3

Runke Bioengineering (Fujian) Co., Ltd. (China)

5

1186

Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01

Runke Bioengineering (Fujian) Co., Ltd. (China)

6

1187

Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding polygalacturonase from Aspergillus luchuensis mut kawachii

AB Enzymes, Inc. (U.S.)

7

1188

D-psicose

Shandong Starlight So True Biological Technology Co., Ltd (China)

8

1189

Dry whole goat milk

Bubs Australia Limited (U.S.)

9

1190

Saccharomyces cerevisiae strain OYR-481 expressing a gene encoding acetolactate decarboxylase from Brevibacillus brevis

Omega Yeast Labs, LLC (U.S.)

10

1191

Ergothioneine produced by Escherichia coli BL-21 (DE3) expressing ergothioneine synthases from Schizosaccharomyces pombe

Shanghai EGT Synbio Group Co., LTD (China)

11

1192

Tannase enzyme preparation produced by Aspergillus oryzae

Mitsubishi Chemical Corporation (Japan)

12

1193

D-psicose

Sichuan Ingia Biosynthetic Co., Ltd. (China)

13

1194

Partially hydrolyzed eggshell membrane powder derived from chicken eggs

ESM Technologies, LLC (U.S.)